Publication Summary

Publication Title: Axsome Therapeutics Initiates PARADIGM Phase 3 Trial of Solriamfetol for the Treatment of Major Depressive Disorder
Authors: GlobeNewswire
Published Date:
Publisher: Financial Post
Topics:
DOI:
Source Url: https://financialpost.com/globe-newswire/axsome-therapeutics-initiates-paradigm-phase-3-trial-of-solriamfetol-for-the-treatment-of-major-depressive-disorder